Literature DB >> 17065214

Cell-type-specific growth restriction of vesicular stomatitis virus polR mutants is linked to defective viral polymerase function.

Derek Ostertag1, Traci M Hoblitzell-Ostertag, Jacques Perrault.   

Abstract

Vesicular stomatitis virus polR mutants synthesize defective RNA replication products in vitro and display growth restriction in some cultured cells (J. L. Chuang, R. L. Jackson, and J. Perrault, Virology 229:57-67, 1997). We show here that a recombinant virus carrying the polR N protein mutation (R179H) yielded approximately 100-fold- and approximately 40-fold-lower amounts of infectious virus than the wild type in mouse L-929 and rat 3Y1 cells, respectively, but only approximately 3-fold less in hamster BHK cells. Virus genome accumulation was inhibited 6- to 10-fold in restricting cells, but transcription was not affected. No defect in encapsidation of replication products was detected, but virus protein accumulation was reduced two- to threefold in both restricting and nonrestricting cells. polR virus particles released from the latter were 5- to 10-fold less infectious than the wild type but showed no difference in protein composition. Phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 (eIF-2alpha) was enhanced approximately 3-fold in polR versus wild-type virus-infected L-929 cells, but neither inhibition of host gene transcription nor inhibition of double-stranded RNA (dsRNA)-activated protein kinase showed significant effects on restriction. Conditioned medium studies revealed no evidence for secretion of antiviral factors from restricting cells. We conclude that the block in polR growth is due to the combined effect of reduced genome replication and lower infectivity of released virus particles and may be due to overproduction of dsRNA. An accompanying paper (D. Ostertag, T. M. Hoblitzell-Ostertag, and J. Perrault, J. Virol. 81:503-513, 2007) provides compelling evidence for the role of dsRNA in this unique restriction phenomenon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065214      PMCID: PMC1797469          DOI: 10.1128/JVI.01217-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  The tdCE and hrCE phenotypes: host range mutants of vesicular stomatitis virus in which polymerase function is affected.

Authors:  C R Pringle
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

2.  Interferon treatment inhibits glycosylation of a viral protein.

Authors:  R K Maheshwari; D K Banerjee; C J Waechter; K Olden; R M Friedman
Journal:  Nature       Date:  1980-10-02       Impact factor: 49.962

3.  ATP dependence of vesicular stomatitis virus transcription initiation and modulation by mutation in the nucleocapsid protein.

Authors:  J Perrault; P W McLear
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

4.  Host range mutants of vesicular stomatitis virus defective in in vitro RNA methylation.

Authors:  S M Horikami; S A Moyer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Cell type specific expression and regulation of murine interferon alpha and beta genes.

Authors:  A Hoss-Homfeld; E C Zwarthoff; R Zawatzky
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

6.  Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?

Authors:  R Schlegel; T S Tralka; M C Willingham; I Pastan
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

7.  Characterization of the non-permissive infection of rabbit cornea cells by vesicular stomatitis virus.

Authors:  D H Hamilton; R W Moyer; S A Moyer
Journal:  J Gen Virol       Date:  1980-08       Impact factor: 3.891

8.  RNP template of vesicular stomatitis virus regulates transcription and replication functions.

Authors:  J Perrault; G M Clinton; M A McClure
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

9.  Differential effect of interferon on glycoprotein and membrane protein of vesicular stomatitis virus released from murine and simian cells.

Authors:  M A Drebot; S H Lee; K R Rozee
Journal:  J Interferon Res       Date:  1984

10.  Further studies of the RNA synthesis phenotype selected during persistent infection with vesicular stomatitis virus.

Authors:  T K Frey; J S Youngner
Journal:  Virology       Date:  1984-07-15       Impact factor: 3.616

View more
  6 in total

1.  Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response.

Authors:  Derek Ostertag; Traci M Hoblitzell-Ostertag; Jacques Perrault
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

2.  The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection.

Authors:  Christian Wisskirchen; Thomas H Ludersdorfer; Dominik A Müller; Eva Moritz; Jovan Pavlovic
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

3.  Insertion of enhanced green fluorescent protein in a hinge region of vesicular stomatitis virus L polymerase protein creates a temperature-sensitive virus that displays no virion-associated polymerase activity in vitro.

Authors:  John B Ruedas; Jacques Perrault
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

4.  Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.

Authors:  Kevin Tartour; Xuan-Nhi Nguyen; Romain Appourchaux; Sonia Assil; Véronique Barateau; Louis-Marie Bloyet; Julien Burlaud Gaillard; Marie-Pierre Confort; Beatriz Escudero-Perez; Henri Gruffat; Saw See Hong; Marie Moroso; Olivier Reynard; Stéphanie Reynard; Elodie Decembre; Najate Ftaich; Axel Rossi; Nannan Wu; Frédérick Arnaud; Sylvain Baize; Marlène Dreux; Denis Gerlier; Glaucia Paranhos-Baccala; Viktor Volchkov; Philippe Roingeard; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2017-09-28       Impact factor: 6.823

5.  Restricted growth of U-type infectious haematopoietic necrosis virus (IHNV) in rainbow trout cells may be linked to casein kinase II activity.

Authors:  J W Park; C H Moon; A Harmache; A R Wargo; M K Purcell; M Bremont; G Kurath
Journal:  J Fish Dis       Date:  2011-02       Impact factor: 2.767

6.  The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation.

Authors:  Nannan Wu; Xuan-Nhi Nguyen; Li Wang; Romain Appourchaux; Chengfei Zhang; Baptiste Panthu; Henri Gruffat; Chloé Journo; Sandrine Alais; Juliang Qin; Na Zhang; Kevin Tartour; Frédéric Catez; Renaud Mahieux; Theophile Ohlmann; Mingyao Liu; Bing Du; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2019-10-10       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.